Literature DB >> 9759935

Biodistribution and gene expression of lipid/plasmid complexes after systemic administration.

R I Mahato1, K Anwer, F Tagliaferri, C Meaney, P Leonard, M S Wadhwa, M Logan, M French, A Rolland.   

Abstract

The objectives of this study were to investigate the influence of physicochemical properties of lipid/plasmid complexes on in vivo gene transfer and biodistribution characteristics. Formulations based on 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA) and novel biodegradable cationic lipids, such as ethyl dioleoyl phosphatidylcholine (EDOPC), ethyl palmitoyl myristyl phosphatidylcholine (EPMPC), myristyl myristoyl carnitine ester (MMCE), and oleyl oleoyl L-carnitine ester (DOLCE), were assessed for gene expression after tail vein injection of lipid/plasmid complexes in mice. Gene expression was influenced by cationic lipid structure, cationic lipid-to-colipid molar ratios, plasmid-to-lipid charge ratios, and precondensation liposome size. Detectable levels of human growth hormone (hGH) in serum, human factor IX (hFIX) in plasma, and chloramphenicol acetyltransferase (CAT) in the lung and liver were observed with positively charged lipid/plasmid complexes prepared from 400-nm extruded liposomes with a cationic lipid-to-colipid ratio of 4:1 (mol/mol). Intravenous administration of lipid/CAT plasmid complexes resulted in distribution of plasmid DNA mainly to the lung at 15 min after injection. Plasmid DNA accumulation in the liver increased with time up to 24 hr postinjection. There was a 10-fold decrease in the amount of plasmid DNA in the lung at 15 min after injection, when the lipid/plasmid complex charge ratio was decreased from 3:1 to 0.5:1 (+/-). Bright fluorescent aggregates were evident in in vivo-transfected lung with the positively charged pCMV-CAT/DOLCE:dioleyl phosphatidylethanolamine (DOPE) (1:1, mol/mol) complexes, while more discrete punctate fluorescence was observed with a 4:1 molar ratio of cationic lipid:colipid formulations. Preinjection of polyanions such as plasmid, dextran sulfate, polycytidic acid, and polyinosinic acid decreased hGH expression, whereas the preinjection of both positively charged and neutral liposomes had no effect on hGH serum levels. Of the cationic lipids tested, DOLCE was found to be the most effective potentially biodegradable cationic lipid. A correlation between gene expression and cationic lipid:colipid ratios and lipid-to-plasmid charge ratio was also observed for DOTMA- and DOLCE-based formulations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759935     DOI: 10.1089/hum.1998.9.14-2083

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  20 in total

Review 1.  In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.

Authors:  Sandrine A L Audouy; Lou F M H de Leij; Dick Hoekstra; Grietje Molema
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications.

Authors:  Luc Wasungu; Marco Scarzello; Gooitzen van Dam; Grietje Molema; Anno Wagenaar; Jan B F N Engberts; Dick Hoekstra
Journal:  J Mol Med (Berl)       Date:  2006-06-08       Impact factor: 4.599

3.  Cell targeting in anti-cancer gene therapy.

Authors:  Mohd Azmi Mohd Lila; John Shia Kwong Siew; Hayati Zakaria; Suria Mohd Saad; Lim Shen Ni; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2004-01

4.  In vivo gene delivery to the liver using novel galactosylated cationic liposomes.

Authors:  S Kawakami; S Fumoto; M Nishikawa; F Yamashita; M Hashida
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

Review 5.  Lipid nanoparticles for gene delivery.

Authors:  Yi Zhao; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

6.  Novel water insoluble lipoparticulates for gene delivery.

Authors:  Darin Y Furgeson; Richard N Cohen; Ram I Mahato; Sung Wan Kim
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

7.  Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.

Authors:  V Fehring; U Schaeper; K Ahrens; A Santel; O Keil; M Eisermann; K Giese; Jörg Kaufmann
Journal:  Mol Ther       Date:  2014-01-06       Impact factor: 11.454

8.  Transferrin-associated lipoplexes as gene delivery systems: relevance of mode of preparation and biophysical properties.

Authors:  Nuno Penacho; Ana Filipe; Sérgio Simões; Maria C Pedroso de Lima
Journal:  J Membr Biol       Date:  2008-02-21       Impact factor: 1.843

9.  Structural and formulation factors influencing pyridinium lipid-based gene transfer.

Authors:  Lin Zhu; Yan Lu; Duane D Miller; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

10.  Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver.

Authors:  C A Fernandez; N J Baumhover; J T Duskey; S Khargharia; K Kizzire; M D Ericson; K G Rice
Journal:  Gene Ther       Date:  2010-08-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.